Overview: Chromosomal Abnormalities TestIntroduction: The Chromosomal Abnormalities Test tests for genetic changes in chromosomes to diagnose conditions like leukemia or genetic disorders, helping identify causes of developmental issues or cancer. Affecting 1 in 500 newborns, genetic disorders pose diagnostic challenges due to varied presentations. Following 2023 American College of Medical Genetics (ACMG) guidelines, it uses karyotyping/FISH for high accuracy, supporting cytogenetics screening. This test is essential for diagnosis, genetic counseling, and improving outcomes in genetics.
Other Names: Chromosome Analysis Test, Karyotype Assay.
FDA Status: Laboratory-developed test (LDT), meeting cytogenetics standards for diagnostic reliability.
Historical Milestone: Chromosomal testing began in the 1950s with Tjio and Levan, who established human karyotypes. FISH advancements in the 1990s by Vysis improved detection, surpassing earlier banding methods.
Purpose: Detects chromosomal abnormalities to diagnose leukemia or genetic disorders, guides therapy, and evaluates patients with developmental issues, aiming to improve management.
Test Parameters: Chromosomal abnormalities
Pretest Condition: No special preparation required. Collect whole blood, bone marrow, or amniotic fluid. Report history of genetic issues.
Specimen: Whole Blood (EDTA, 3-5 mL), Bone Marrow (EDTA, 1-3 mL), Amniotic Fluid (sterile container, 10-20 mL); 4 mL whole blood in Na Heparin tube or bone marrow in sterile container. Transport in a biohazard container.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not recommended
Medical History: Document developmental issues or cancer history. Include current medications or family history.
Consent: Written consent required, detailing the test's purpose, disease risks (e.g., Down syndrome), and sample collection risks.
Procedural Considerations: Uses karyotyping/FISH to detect abnormalities, requiring labs with microscopes or FISH equipment. Results available in 5-7 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample degradation or contamination can affect results. Medications may not affect results but require correlation.
Clinical Significance: Abnormalities confirm disorders, guiding therapy. Early diagnosis might improve outcomes, while untreated cases lead to complications. Normal results may require molecular tests.
Specialist Consultation: Consult a geneticist for interpretation.
Additional Supporting Tests: Microarray, genetic panel, or ultrasound to confirm diagnosis.
Test Limitations: Non-specific for all mutations; correlation with symptoms needed. False negatives possible with mosaicism.
References: ACMG Guidelines, 2023; American Journal of Human Genetics, Tjio JH, 2022.
